neuroscience-and-neuropharmacology-research

Nature Communications
Frontiers in Pharmacology | New and Recent Articles

BackgroundBiktarvy, a second-generation integrase strand-transfer inhibitor, is approved for treating human immunodeficiency virus (HIV) in patients with no known resistance to its components. This study compared adverse events (AEs) associated with biktarvy based on data from the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database and real-world evidence fr…

infectious-diseasemedicinepharmacology
Frontiers in Pharmacology | New and Recent Articles

BackgroundPlant-Derived Exosome-Like nanoparticles (PELNs) are vital bioactive vesicles from medicinal plants, containing protective flavonoids, polyphenols, alkaloids, terpenoids, saponins, polysaccharides, and microRNAs. These compounds play crucial roles in PELNs’ anti-inflammatory and other pharmacological effects. PELNs show promise as a treatment in animal experiments for ulcerative colitis…

gastroenterologymedicinepharmacology
Frontiers in Pharmacology | New and Recent Articles

BackgroundCardiovascular diseases remain an urgent global health concern addressed by multiple clinical guidelines. Atherothrombosis is characterised by thrombus formation following disruption of atherosclerotic plaque, leading to major adverse cardiovascular events, such as myocardial infarction and stroke. Platelet hyperactivity is a key driver of these outcomes, leading causes of morbidity and…

cardiologymedicinepharmacology
Frontiers in Pharmacology | New and Recent Articles

ObjectiveF. africana Lehm (Poaceae) is a perennial grass traditionally used in ethnomedicine for the treatment of gastrointestinal disorders and wound healing. Despite its traditional relevance, its phytochemical composition and pharmacological activities remain largely unexplored. This study aimed to comprehensively characterize the phytochemical and elemental profiles of Fingerhuthia africana a…

ethnomedicinemedicinepharmacology
Frontiers in Pharmacology | New and Recent Articles

BackgroundLecanemab and donanemab are anti-amyloid-β (Aβ) monoclonal antibodies recently approved for the treatment of Alzheimer’s disease (AD). Although both agents have demonstrated therapeutic potential, their post-marketing adverse event reporting profiles remain insufficiently characterized and compared in spontaneous reporting systems. This study aimed to systematically compare adverse even…

medicineneurologypharmacology
Frontiers in Pharmacology | New and Recent Articles

BackgroundLigustilide (LIG), a natural phthalide compound mainly isolated from Angelica sinensis and Ligusticum chuanxiong, has attracted increasing attention because of its diverse pharmacological activities, including anti-inflammatory, antioxidant, anti-apoptotic, and neuroprotective effects. Emerging studies suggest that LIG may have therapeutic relevance in central nervous system (CNS) disor…

medicineneurosciencepharmacology
Frontiers in Pharmacology | New and Recent Articles

Ischemic stroke currently lacks evidence-based neuroprotective agents, primarily due to the challenge of timely intervention, which often occurs after the onset of irreversible neuronal damage. To address this, this study investigates the PARthanatos pathway, a form of regulated cell death triggered by DNA damage. Utilizing MNNG-induced cellular PARthanatos models, we screened a library of 2,939 …

infectious-diseasemedicineneuroprotectionpharmacology
Frontiers in Pharmacology | New and Recent Articles

BackgroundThis study aims to investigate the potential association between 13 disease-modifying immunosuppressive drugs used to treat multiple sclerosis and intervertebral disc herniation, thereby filling a gap in pharmacovigilance research in this field.Materials and methodsWe extracted adverse event reports from the FAERS database covering 2005 to 2025. Disproportionality analyses using four es…

infectious-diseasemedicinepharmacology
The Medical News

A new study led by researchers at The University of Texas at El Paso found that use of weight loss drugs like Ozempic and other GLP-1s is associated with a lower risk of developing alcohol, opioid, nicotine and cocaine use disorders.

medicinepharmacologypublic-health
CU Anschutz Newsroom
Latest from Live Science
The Daily Galaxy –Great Discoveries Channel
Scientific American
Newswise: Latest News

Glucagon-like peptide-1 (GLP-1) is a hormone produced primarily in the gut that helps regulate blood sugar levels, appetite, food cravings, and eating behavior. Scientists have developed modified, longer-lasting versions called GLP-1 receptor agonists (GLP-1RAs) that can be used as medications - and potentially treat alcohol use disorder (AUD). Findings from both rodent and human studies will be …

biochemistrybiologymedicinepharmacology
Nature Communications

Nature Communications, Published online: 21 June 2026; doi:10.1038/s41467-026-74481-3 Hepatic stellate cell (HSC) activation drives liver fibrosis. Here, the authors show that apoptosis-resistant E3 ubiquitin protein ligase 1 (AREL1) is upregulated in HSCs of patients with metabolic-associated steatohepatitis (MASH) and promotes fibrosis via the ILK–PI3K–AKT pathway. Targeting AREL1 with vitamin …

medicineoncologypharmacology
Lifeboat News: The Blog
Biological sciences : Scientific Reports subject feeds
Knowridge Science Report

Medicines called GLP-1 receptor agonists have become some of the most talked-about drugs in recent years. They were first developed to help people with type 2 diabetes manage their blood sugar levels. Later, doctors discovered that these medicines could also help people lose weight by reducing appetite and making them feel full for longer. As […] The post Popular Diabetes and Weight-Loss Drugs Ma…

medicinepharmacologypublic-health
Latest Science News -- ScienceDaily

Compounds responsible for the aroma of cannabis and many other plants may offer a surprising new way to relieve chronic pain. Researchers found that several cannabis-derived terpenes significantly reduced pain in mouse models of fibromyalgia and post-surgical pain, with one terpene, geraniol, showing especially strong effects. Unlike THC, these compounds are not associated with psychoactive effec…

medicinepharmacology
research.ioresearch.io

Sign up to keep scrolling

Create your feed subscriptions, save articles, keep scrolling.

Already have an account?